Latest Articles and Analysis

The Centers for Disease Control and Prevention (CDC) released its National HIV Prevention and Care Objectives: 2026 Update on May 18, 2026, presenting the most recent national picture of the U.S. HIV...

On May 4, 2026, Health Secretary Robert F. Kennedy Jr. closed a daylong Make America Healthy Again (MAHA) Institute summit on mental health and overmedicalization by announcing a federal initiative...

On March 6, 2026, the Iowa Department of Health and Human Services filed a nine-page complaint in Polk County District Court alleging that NuCara Specialty Pharmacy failed to remit more than $22...

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

ADAPs achieve 87% viral suppression but face funding crisis as multiple policies erode 340B rebates.

Florida ADAP cuts eligibility from 400% to 130% FPL, threatening 16,000 PLWHA.